Cancer risk and low-penetrance susceptibility genes in gene-environment interactions

被引:227
作者
Shields, PG
Harris, CC
机构
[1] NCI, Human Carcinogenesis Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA
[2] Georgetown Univ, Med Ctr, Canc Genet & Epidemiol Program, Vincent T Lombardi Canc Res Ctr, Washington, DC 20007 USA
关键词
D O I
10.1200/JCO.2000.18.11.2309
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To provide a concise review for human cancer risk related to low-penetrance genes and their effects on environmental carcinogen exposure. Methods: Citation of relevant and recent references for molecular epidemiology, focusing on lung cancer, ethical issues, and some clinical implications of recent molecular epidemiology studies. Results: Law-penetrance genes contribute to cancer risk by augmenting the effects of carcinogen exposures. These exposures can be measured in the body through molecular dosimetry (ie, the amount of DNA damage), which reflects ct biologically effective dose. The examination of tumors and the mutations within tumor suppressor genes, such as p53, can provide etiologic clues for both exposure and susceptibility. Although many studies have focused on carcinogen metabolism and cancer risk, more recent studies are considering DNA repair, Also, we are learning that behavior, such as tobacco addiction, also may be genetically controlled. Conclusion: Sporadic cancers are caused by gene(n)-environment(n) interactions rather than a dominant effect by a specific gene, environmental exposure, or gene-environment interaction. New paradigms, where we categorize genes as caretaker or gatekeeper genes, will allow for new hypotheses to be tested and will require advanced methods of analysis. The goal of molecular epidemiology is to develop risk assessment models for individuals, but currently the most achievable goal will be population risk assessment and a better understanding of carcinogenesis. J Clin Oncol 18:2309-2315. (C) 2000 by American Society of Clinical Oncology.
引用
收藏
页码:2309 / 2315
页数:7
相关论文
共 66 条
[1]   METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER [J].
AYESH, R ;
IDLE, JR ;
RITCHIE, JC ;
CROTHERS, MJ ;
HETZEL, MR .
NATURE, 1984, 312 (5990) :169-170
[2]   Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women [J].
Bennett, WP ;
Alavanja, MCR ;
Blomeke, B ;
Vähäkangas, KH ;
Castrén, K ;
Welsh, JA ;
Bowman, ED ;
Khan, MA ;
Flieder, DB ;
Harris, CC .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (23) :2009-2014
[3]   A ROLE FOR SUNLIGHT IN SKIN-CANCER - UV-INDUCED P53 MUTATIONS IN SQUAMOUS-CELL CARCINOMA [J].
BRASH, DE ;
RUDOLPH, JA ;
SIMON, JA ;
LIN, A ;
MCKENNA, GJ ;
BADEN, HP ;
HALPERIN, AJ ;
PONTEN, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :10124-10128
[4]   ASSOCIATION BETWEEN CIGARETTE-SMOKING AND MUTATION OF THE P53 GENE IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].
BRENNAN, JA ;
BOYLE, JO ;
KOCH, WM ;
GOODMAN, SN ;
HRUBAN, RH ;
EBY, YJ ;
COUCH, MJ ;
FORASTIERE, AA ;
SIDRANSKY, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (11) :712-717
[5]   SELECTIVE G-MUTATION TO T-MUTATION OF P53 GENE IN HEPATOCELLULAR-CARCINOMA FROM SOUTHERN AFRICA [J].
BRESSAC, B ;
KEW, M ;
WANDS, J ;
OZTURK, M .
NATURE, 1991, 350 (6317) :429-431
[6]   Recommendations for follow-up care of individuals with an inherited predisposition to cancer .2. BRCA1 and BRCA2 [J].
Burke, W ;
Daly, M ;
Garber, J ;
Botkin, J ;
Kahn, MJE ;
Lynch, P ;
McTierman, A ;
Offit, K ;
Perlman, J ;
Petersen, G ;
Thomson, E ;
Varricchio, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (12) :997-1003
[7]   Recommendations for follow-up care of individuals with an inherited predisposition to cancer .1. Hereditary nonpolyposis colon cancer [J].
Burke, W ;
Petersen, G ;
Lynch, P ;
Botkin, J ;
Daly, M ;
Garber, J ;
Kahn, MJE ;
McTiernan, A ;
Offit, K ;
Thomson, E ;
Varricchio, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (11) :915-919
[8]   LUNG-CANCER AND THE DEBRISOQUINE METABOLIC PHENOTYPE [J].
CAPORASO, NE ;
TUCKER, MA ;
HOOVER, RN ;
HAYES, RB ;
PICKLE, LW ;
ISSAQ, HJ ;
MUSCHIK, GM ;
GREENGALLO, L ;
BUIVYS, D ;
AISNER, S ;
RESAU, JH ;
TRUMP, BF ;
TOLLERUD, D ;
WESTON, A ;
HARRIS, CC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (15) :1264-1272
[9]   INCREASED MUTAGEN SENSITIVITY IN HEAD-AND-NECK SQUAMOUS-CELL CARCINOMA PATIENTS, PARTICULARLY THOSE WITH MULTIPLE PRIMARY TUMORS [J].
CLOOS, J ;
BRAAKHUIS, BJM ;
STEEN, I ;
COPPER, MP ;
DEVRIES, N ;
NAUTA, JJP ;
SNOW, GB .
INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (06) :816-819
[10]   Genetic susceptibility to head and neck squamous cell carcinoma [J].
Cloos, J ;
Spitz, MR ;
Schantz, SP ;
Hsu, TC ;
Zhang, ZF ;
Tobi, H ;
Braakhuis, BJM ;
Snow, GB .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (08) :530-535